215 related articles for article (PubMed ID: 9080145)
1. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA.
Crisci R; Di Cesare E; Lupattelli L; Coloni GF
Eur J Cardiothorac Surg; 1997 Feb; 11(2):214-7. PubMed ID: 9080145
[TBL] [Abstract][Full Text] [Related]
2. Intrathoracic lymph node evaluation by CT and MRI with histopathologic correlation in non-small cell bronchogenic carcinoma.
Georgian D; Rice TW; Mehta AC; Wiedemann HP; Stoller JK; O'Donovan PB
Clin Imaging; 1990 Mar; 14(1):35-40. PubMed ID: 2157544
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer.
Kono M; Adachi S; Kusumoto M; Sakai E
J Thorac Imaging; 1993; 8(1):18-26. PubMed ID: 8418316
[TBL] [Abstract][Full Text] [Related]
4. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT.
Cascade PN; Gross BH; Kazerooni EA; Quint LE; Francis IR; Strawderman M; Korobkin M
AJR Am J Roentgenol; 1998 Apr; 170(4):927-31. PubMed ID: 9530036
[TBL] [Abstract][Full Text] [Related]
5. [Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil].
Heuck A; Scheidler J; Kimmig R; Müller-Lisse U; Steinborn M; Helmberger T; Reiser M
Rofo; 1997 Mar; 166(3):210-4. PubMed ID: 9156591
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma.
Manfredi R; Pirronti T; Bonomo L; Marano P
MAGMA; 1996; 4(3-4):257-62. PubMed ID: 9220416
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
8. [Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph nodes in rabbit models].
Feng Y; Zhang GX; Wang H; Hu YS; Wang XF; Zheng LF
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):813-8. PubMed ID: 21223685
[TBL] [Abstract][Full Text] [Related]
9. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
Torricelli P; Montanari N; De Santis M; Pollastri C
Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
[TBL] [Abstract][Full Text] [Related]
10. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
[TBL] [Abstract][Full Text] [Related]
11. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
13. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.
Harika L; Weissleder R; Poss K; Zimmer C; Papisov MI; Brady TJ
Magn Reson Med; 1995 Jan; 33(1):88-92. PubMed ID: 7891541
[TBL] [Abstract][Full Text] [Related]
14. [The magnetic resonance tomographic differential diagnosis between reactively enlarged lymph nodes and cervical lymph node metastases].
Steinkamp HJ; Heim T; Schubeus P; Schörner W; Felix R
Rofo; 1992 Oct; 157(4):406-13. PubMed ID: 1391845
[TBL] [Abstract][Full Text] [Related]
15. Enlarged mediastinal lymph nodes in bronchogenic carcinoma: assessment with dynamic contrast-enhanced MR imaging. Work in progress.
Laissy JP; Gay-Depassier P; Soyer P; Dombret MC; Murciano G; Sautet A; Aubier M; Menu Y
Radiology; 1994 Apr; 191(1):263-7. PubMed ID: 8134585
[TBL] [Abstract][Full Text] [Related]
16. [Staging of rectal cancer: assessment with Gd-DTPA enhanced MR imaging].
Okizuka H; Sugimura K; Shiraki S; Ishida T
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):403-9. PubMed ID: 8493073
[TBL] [Abstract][Full Text] [Related]
17. Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results.
Mönninghoff C; Maderwald S; Theysohn JM; Schütt P; Gauler T; Kraff O; Ladd ME; Ladd SC; Wanke I
Rofo; 2010 Sep; 182(9):764-72. PubMed ID: 20544578
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of mediastinal lymph nodes in the course of lung diseases in dynamic contrast-enhanced magnetic resonance imaging].
Dobkowski P; Bestry I; Wiatr E; Remiszewski P; Zych J
Pol Merkur Lekarski; 2002 Dec; 13(78):477-80. PubMed ID: 12666445
[TBL] [Abstract][Full Text] [Related]
19. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
[TBL] [Abstract][Full Text] [Related]
20. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
